Skip to search formSkip to main contentSkip to account menu

BCL9 protein, human

Known as: BCL9, BCL-9, B-Cell Lymphoma 9 Protein 
Expressed in thymus, prostate, testis, ovary, small intestine, spleen, colon, and blood, 85-kb human BCL9 Gene at 1q21 encodes 1426-aa 150-kD nuclear… 
National Institutes of Health

Related topics

Related topics

18 relations
BCL7A protein, humanBCL9 geneCell NucleusColon structure (body structure)

Broader (1)

Neoplasm Proteins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
MiR-30c exerts tumor suppressive functions in colorectal carcinoma by directly targeting BCL9.
OBJECTIVE Colorectal carcinoma (CRC) remains a leading health threat worldwide due to its high mortality. MicroRNA (miR-30c) is… 
2019
2019
miR-30 a inhibits breast cancer progression through the Wnt / β-catenin pathway
Background: miR-30a is a microRNA associated with the progression of malignant tumors such as gastric cancer, colon cancer… 
2015
2015
ESSENTIAL ROLE OF B-CELL LYMPHOMA-9 IN HUMAN BREAST DUCTAL CARCINOMA IN SITU PROGRESSION TO INVASIVE BREAST CANCER
B-cell lymphoma-9 (BCL9) is a recently identified co-activator of β-catenin mediated transcription. BCL9 has been shown to… 
2014
2014
Abstract 4966: Establishment and characterization of a paired human non-small cell lung cancer cell lines from primary cancer and metastasis lymph node
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Objective: Lung cancer has become one of the leading… 
2013
2013
Dissecting the ß-catenin-dependent and -independent functions of BCL9 and BCL9-2 in intestinal tumorigenesis
The Wnt/s-catenin signaling pathway is highly conserved and plays an important role during embryonic development, in adult… 
2012
2012
Histone decoding by the Pygo-BCL9 complex : a target for small molecule inhibition of Wnt signalling
2012
2012
Characterization of the Oncogenic Role of BCL9-2 in Breast Tumorigenesis
One of a few highly conserved signaling pathways, which regulate cell proliferation and tissue organization during… 
2012
2012
Stabilization of BCL9 been to α using helix, targeting the Wnt signaling has been deregulated in cancer
The present invention, for use as therapeutic agents, to provide a structurally constrained peptide by hydrocarbon stapling… 
2010
2010
The Expression of BCL9 and VEGF in Colorectal Cancer and Their Clinical Significance
To explore the relationship between the expression of B-cell lymphoma 9(BCL9)and vascular endothelial growth factor(VEGF)in… 
2000
2000
Cytogenetic and molecular studies of variant Ph' translocations.
including acute lymphoblastic leukemias (ALL) and non-Hodgkin’s lymphomas. Recently, a novel gene (BCL9), was cloned from a t(1…